Testosterone and testing

A normal testosterone blood result does not mean prior use is undetectable. The product, use history, sample and laboratory method all matter; an ester table cannot promise a negative-test date.

First identify what is being tested. Routine TRT bloodwork and anti-doping analysis answer different questions.

Start with the test, not a countdown

Treatment bloodwork

How much hormone is circulating? A measurement at one sampling time.

General drug screen

What does this ordered panel include? Ask the testing organization.

Anti-doping analysis

Do the profile or origin indicate administration? May combine several methods and samples.

A normal testosterone result does not certify that prior use is undetectable.

First, which kind of test do you mean?

For prescribed treatment, use the monitoring plan for that product. For a workplace or other general screen, ask the testing organization what was ordered. In sport, check the relevant anti-doping organization’s therapeutic-use requirements with your prescriber.

The US Anti-Doping Agency explains why parent-drug half-life and detection are different. A five-half-life calculation is a decay illustration, not a clearance certificate.

What the steroid profile measures

WADA’s urinary steroid-profile document describes testosterone, epitestosterone and other markers and ratios. Repeated samples can contribute to the steroidal Athlete Biological Passport. The assessment therefore goes beyond looking for one unusual molecule. WADA TD2021EAAS

A result that looks ordinary in isolation is not a guarantee that the longitudinal pattern or another analytical method will be unremarkable.

How a lab can look for testosterone from outside the body

One method compares the carbon “fingerprint” of selected steroids with reference compounds in the same sample. Its technical name is GC/C/IRMS (isotope-ratio mass spectrometry). WADA’s technical document permits investigation even when profile markers fall within normal ranges. That is why a normal-looking profile is not proof of a negative determination. WADA TD2022IRMS

The method is answering a question about origin. A plot of blood concentrations does not include the measurements it requires.

What an ester half-life does describe

An ester affects release from a preparation. After cleavage, the hormone is testosterone. For example, Nebido’s product information distinguishes release from its depot, cleavage and subsequent testosterone metabolism. Nebido pharmacokinetic information

Even a well-supported concentration model lacks the individual’s full urinary-marker history and the laboratory’s analytical information. Multiplying a half-life by five cannot manufacture a negative-test date.

Read detection studies as observations

A human testosterone-enanthate study found that analytical approaches added different information about administration. It supports combining passport interpretation and isotope-ratio analysis rather than treating one fixed ratio as decisive. Strahm et al., 2015

When a study reports detection at its final sampling point, that is not evidence that the next sample would be negative. Check the product, sampling plan, participants and marker before repeating a duration from a table.

Common questions

Does a normal serum testosterone result rule out prior-use detection? No. Blood concentration, urinary patterns and isotopic origin are different measurements.

Can changing esters make a detection calculator reliable? No. A different release profile does not supply the missing analytical and individual information.

What if testosterone is prescribed? Discuss treatment and any therapeutic-use requirements with the prescriber and relevant anti-doping organization. Do not alter treatment according to an online countdown.

Sources and retained correction

The linked WADA documents explain the methods described here; this page does not claim to reproduce every current testing rule.

WADA method documents rechecked October 12, 2026; these explain the principles, not a complete current sport rulebook. No test-evasion schedule or personal clearance estimate is provided.